British Patient Capital announces £25m commitment to DDF-2
Funding | Mar 20, 2025 | British Patient Capital
British Patient Capital, a subsidiary of the British Business Bank, has committed £25 million to the Dementia Discovery Fund 2 (DDF-2), managed by SV Health Investors. This follows a previous investment of £24 million into the original Dementia Discovery Fund (DDF-1). The DDF is a dedicated venture capital fund focusing on innovative therapeutics for dementia, a major global health issue affecting 55 million people worldwide. Since its inception in 2015, DDF has developed a portfolio of 19 promising companies, with 11 assets now in clinical stages and numerous strategic pharma partnerships. With British Patient Capital's new commitment, DDF-2 has reached its target of raising $250 million. This fund aims to build on the decade-long advances in neuroscience and neurodegenerative diseases to further understand and treat dementia, providing crucial finance for breakthrough first-in-class therapeutics.
Sectors
- Venture Capital
- Healthcare & Biotechnology
Geography
- United Kingdom – British Patient Capital, the investing firm, is a UK-based entity. The geography of the investment decision and management is anchored in the UK.
Industry
- Venture Capital – This sector involves firms or funds investing in early-stage, high-potential growth companies. The Dementia Discovery Fund is an example of this, being a specialized venture capital fund investing in dementia therapeutics.
- Healthcare & Biotechnology – This sector pertains to companies involved in the production and services of medical research and products. The investment focuses on dementia therapeutics, clearly aligning with this industry.
Financials
- £25 million – The amount invested by British Patient Capital into the Dementia Discovery Fund 2.
- $250 million – The target fundraising amount for the Dementia Discovery Fund 2, now achieved.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| British Patient Capital | Investor | Company | A commercial subsidiary of the British Business Bank, involved in providing funding. |
| SV Health Investors | Fund Manager | Company | A manager of the Dementia Discovery Fund, focusing on healthcare investments. |
| Dementia Discovery Fund 2 | Target Fund | Company | A specialized venture capital fund investing in companies developing dementia therapeutics. |